GOLDMAN SACHS GROUP INC

Holdings History for Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Symbol: BCAX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$9,295,731	552,331	+319,570	+137%	$16.83	Q4 2025
30 Sep 2025	0%	+0%	$3,675,296	232,761	+80,904	+53%	$15.79	Q3 2025
30 Jun 2025	0%	+0%	$1,410,752	151,857	+26,162	+21%	$9.29	Q2 2025
31 Mar 2025	0%	-0%	$1,637,806	125,695	-54,054		$13.03	Q1 2025
31 Dec 2024	0%	+0%	$3,131,228	179,749	+77,854	+76%	$17.42	Q4 2024
30 Sep 2024	0%	+0%	$2,595,266	101,895	+101,895	NEW	$25.47	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.